Evidence map›Paper›PMID 28710306›Full record

ArticleBMJ case reports2017

Ruxolitinib treatment in an infant with JAK2+ polycythaemia vera-associated Budd-Chiari syndrome.

Mehmet Enes Coskun, Sue Height, Anil Dhawan, Nedim Hadzic

Open access · bronzeAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. [Emphasis on the etiological diagnosis and management of non-cirrhotic portal hypertension].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Review
  3. Review
  4. Splanchnic Vein Thrombosis in the Myeloproliferative Neoplasms.Current hematologic malignancy reports · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Mehmet Enes CoskunDepartment of Pediatrics, Gaziantep Universitesi Tip Fakultesi, Gaziantep, Turkey.
Sue HeightPaediatric Haematology, King's College Hospital NHS Foundation Trust, London, UK.
Anil DhawanPediatric Gastroenterolgy, Hepatololgy and Nutrition, King's College Hospital NHS Foundation Trust, London, UK.
Nedim HadzicPediatric Gastroenterolgy, Hepatololgy and Nutrition, King's College Hospital NHS Foundation Trust, London, UK.
King's College Hospital NHS Foundation Trust · GBGaziantep University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Budd-Chiari syndrome (BCS) is caused by hepatic venous outflow obstruction commonly seen with myeloproliferative neoplasms (MPNs). Polycythaemia vera (PV) is a very rare MPN in childhood. This is the youngest reported patient diagnosed with PV and BCS secondary to

Indexed as

AscitesBudd-Chiari SyndromeChild, PreschoolDiagnosis, DifferentialFemaleHumansJanus Kinase 2NitrilesPolycythemia VeraPyrazolesPyrimidinesJAK2 protein, humanJanus Kinase 2NitrilesPyrazolesPyrimidinesruxolitinibhaematologyhaematology (drugs and medicines)liver disease

Identifiers

PMID28710306
PMCPMC5535054
OpenAlexW2735615381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.